CN106334178A - Alopecia-preventing and hair growth promoting liniment and preparation method thereof - Google Patents
Alopecia-preventing and hair growth promoting liniment and preparation method thereof Download PDFInfo
- Publication number
- CN106334178A CN106334178A CN201610955858.2A CN201610955858A CN106334178A CN 106334178 A CN106334178 A CN 106334178A CN 201610955858 A CN201610955858 A CN 201610955858A CN 106334178 A CN106334178 A CN 106334178A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- liniment
- vitamin
- western medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000865 liniment Substances 0.000 title claims abstract description 54
- 229940040145 liniment Drugs 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 201000004384 Alopecia Diseases 0.000 title abstract description 25
- 230000003779 hair growth Effects 0.000 title abstract description 7
- 230000001737 promoting effect Effects 0.000 title abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 59
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims abstract description 32
- 230000002265 prevention Effects 0.000 claims abstract description 30
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 16
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 11
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 9
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 9
- 210000004209 hair Anatomy 0.000 claims description 34
- 239000002994 raw material Substances 0.000 claims description 28
- 229940088594 vitamin Drugs 0.000 claims description 26
- 229930003231 vitamin Natural products 0.000 claims description 26
- 235000013343 vitamin Nutrition 0.000 claims description 26
- 239000011782 vitamin Substances 0.000 claims description 26
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 16
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 claims description 15
- 241000208340 Araliaceae Species 0.000 claims description 15
- 229930003802 tocotrienol Natural products 0.000 claims description 15
- 239000011731 tocotrienol Substances 0.000 claims description 15
- 235000019148 tocotrienols Nutrition 0.000 claims description 15
- 235000011201 Ginkgo Nutrition 0.000 claims description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 11
- 229960001295 tocopherol Drugs 0.000 claims description 9
- 229930003799 tocopherol Natural products 0.000 claims description 9
- 239000011732 tocopherol Substances 0.000 claims description 9
- 235000010384 tocopherol Nutrition 0.000 claims description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 150000002948 pantothenic acids Chemical class 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 235000014101 wine Nutrition 0.000 claims description 6
- 241001597008 Nomeidae Species 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 claims description 4
- 230000035558 fertility Effects 0.000 claims description 4
- 235000019991 rice wine Nutrition 0.000 claims description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 2
- 244000194101 Ginkgo biloba Species 0.000 claims 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 1
- 240000002853 Nelumbo nucifera Species 0.000 claims 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 abstract description 21
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract description 8
- 206010013663 drug dependence Diseases 0.000 abstract description 7
- 208000011117 substance-related disease Diseases 0.000 abstract description 7
- 229940011671 vitamin b6 Drugs 0.000 abstract description 7
- 244000228451 Stevia rebaudiana Species 0.000 abstract description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 abstract 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 240000002234 Allium sativum Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 235000004866 D-panthenol Nutrition 0.000 abstract 1
- 239000011703 D-panthenol Substances 0.000 abstract 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 240000006927 Foeniculum vulgare Species 0.000 abstract 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000003915 Lophatherum gracile Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 229960002255 azelaic acid Drugs 0.000 abstract 1
- 229960003949 dexpanthenol Drugs 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 235000004611 garlic Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229940109850 royal jelly Drugs 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 241000218628 Ginkgo Species 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 240000005827 Phyllostachys nigra Species 0.000 description 1
- 235000010717 Phyllostachys nigra Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses alopecia-preventing and hair growth promoting liniment which contains traditional Chinese medicine components and western medicine components. The traditional Chinese medicine components include ginseng, radix angelica sinensis, garlic, Chinese dodder seeds, radix rehmanniae recen, radix sophorae flavescentis, rhizoma polygonati, fennel, stevia rebaudiana, glossy privet fruits, eucommia barks, lophatherum gracile, cacumen biotae, mint, fleece-flower root, Ligusticum chuanxiong Hort, gingkgo leaves, Chinese wolfberry fruits, divaricate saposhnikovia roota, achyranthes roots, akebiae fructus and dried ginger, and the western medicine components include vitamin B6, vitamin E, D-panthenol, pantothenic acid, royal jelly and azelaic acid. The invention further discloses a preparation method of the alopecia-preventing and hair growth promoting liniment. The alopecia-preventing and hair growth promoting liniment achieve alopecia prevention and hair growth promotion through the synergistic effect of the traditional Chinese medicine components and the western medicine components, and a user has no drug dependence in use.
Description
Technical field
The present invention relates to a kind of phalacrosis prevention and hair generation liniment and preparation method thereof.
Background technology
Alopecia includes normal alopecia and pathologic alopecia, and the hair normally coming off is the hair being in catagen and resting stage
Send out, pathologic alopecia refers to that hair is abnormal or excessively comes off.The reason pathologic alopecia, mainly has: nervous alopecia, androgen
The alopecia of source property, Nutrition and Metabolism alopecia, alopecia of chemical origin etc..Alopecia can be divided into temporary alopecia and permanent alopecia again, temporary
Alopecia is primarily due to hair follicle blood supply minimizing or local nerve regulatory function occurs obstacle, leads to hair follicle malnutrition, draws
Play temporary alopecia, permanent alopecia is primarily due to pathological changes and causes hair follicle to damage, the permanent alopecia causing.
The product of phalacrosis prevention and hair generation is more at present, and including tcm product and Western medicine product, tcm product takes effect relatively slowly, and Western medicine produces
Product would generally have side effects, and current phalacrosis prevention and hair generation product can make user produce drug dependence.
Content of the invention
The invention mainly solves the technical problem of providing a kind of phalacrosis prevention and hair generation liniment and preparation method thereof, Chinese medicine can be passed through
Composition and western medicine composition synergism, realize phalacrosis prevention and hair generation, and no drug dependence.
For solving above-mentioned technical problem, the present invention provides a kind of phalacrosis prevention and hair generation liniment, including Chinese medicinal components and western medicine component,
Chinese medicinal components include Radix Ginseng, Radix Angelicae Sinensis, Bulbus Allii, Semen Cuscutae, Radix Rehmanniae, Radix Sophorae Flavescentiss, Rhizoma Polygonati, Fructus Foeniculi, Folium Stevlae Rebaudianae, Fructus Ligustri Lucidi, the Cortex Eucommiae, light
Folium Bambusae, Cacumen Platycladi, Herba Menthae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, Folium Ginkgo, Fructus Lycii, Herba Ecliptae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, covering, Rhizoma Zingiberiss, Western medicine
Component includes vitamin b6, vitamin e, d- pantothenylol, pantothenic acid, Lac regis apis, azelaic acid.
Wherein, Chinese medicinal components by weight, including Radix Ginseng 10-30 part, Radix Angelicae Sinensis 10-40 part, Bulbus Allii 10-50 part, Herba cuscutae
Sub- 10-30 part, Radix Rehmanniae 20-50 part, Radix Sophorae Flavescentiss 10-30 part, Rhizoma Polygonati 2-10 part, Fructus Foeniculi 20-50 part, Folium Stevlae Rebaudianae 20-50 part, Fructus Ligustri Lucidi
Sub- 10-30 part, Cortex Eucommiae 2-10 part, Herba Lophatheri 10-30 part, Cacumen Platycladi 2-10 part, Herba Menthae 2-10 part, Radix Polygoni Multiflori 10-45 part, Rhizoma Chuanxiong
10-30 part, Folium Ginkgo 10-30 part, Fructus Lycii 15-45 part, Herba Ecliptae 8-15 part, Radix Saposhnikoviae 5-10 part, Radix Achyranthis Bidentatae 10-30 part, covering
Sub- 10-30 part, Rhizoma Zingiberiss 10-30 part;Western medicine component by weight, including 2-10 part vitamin b6,2-10 part vitamin e, 2-
10 parts of d- pantothenylol, 10-20 part pantothenic acid, 5-15 part Lac regis apis, 10-30 part azelaic acid.
Wherein, Chinese medicinal components by weight, including 20 parts of Radix Ginseng, 30 parts of Radix Angelicae Sinensis, 30 parts of Bulbus Allii, 20 parts of Semen Cuscutae, are given birth to
40 parts of Radix Rehmanniae, 20 parts of Radix Sophorae Flavescentiss, 8 parts of Rhizoma Polygonati, 35 parts of Fructus Foeniculi, 35 parts of Folium Stevlae Rebaudianae, 20 parts of Fructus Ligustri Lucidi, 7 parts of the Cortex Eucommiae, 20 parts of Herba Lophatheri,
6 parts of Cacumen Platycladi, 6 parts of Herba Menthae, 30 parts of Radix Polygoni Multiflori, 20 parts of Rhizoma Chuanxiong, 20 parts of Folium Ginkgo, 40 parts of Fructus Lycii, 10 parts of Herba Ecliptae, 9 parts of Radix Saposhnikoviae,
25 parts of Radix Achyranthis Bidentatae, covering sub 20 parts, 25 parts of Rhizoma Zingiberiss;Western medicine component by weight, including 8 parts of vitamin b6,8 parts of vitamin e,
8 parts of d- pantothenylol, 15 parts of pantothenic acids, 12 parts of Lac regis apis, 20 parts of azelaic acid.
Wherein, vitamin e is the mixture of tocopherol, tocotrienol or tocopherol and tocotrienol, wherein, fertility
Phenol is Tocopheryl derivatives, and tocotrienol is tocotrienol derivant.
Wherein, each composition in Chinese medicinal components is the extract of each composition.
For solving above-mentioned technical problem, the present invention provides a kind of preparation method of above-mentioned phalacrosis prevention and hair generation liniment, including following
Step: the raw material of Chinese medicine being used for preparing liniment is pulverized, raw material of Chinese medicine includes Radix Ginseng, Radix Angelicae Sinensis, Bulbus Allii, Semen Cuscutae, the Radix Rehmanniae
Huang, Radix Sophorae Flavescentiss, Rhizoma Polygonati, Fructus Foeniculi, Folium Stevlae Rebaudianae, Fructus Ligustri Lucidi, the Cortex Eucommiae, Herba Lophatheri, Cacumen Platycladi, Herba Menthae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, Folium Ginkgo, Chinese holly
Qi, Herba Ecliptae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, covering, Rhizoma Zingiberiss;By pulverize after raw material of Chinese medicine be used for preparing the Western medicine raw material of liniment
Mixed, Western medicine raw material includes vitamin b6, vitamin e, d- pantothenylol, pantothenic acid, Lac regis apis, azelaic acid;To mix
Raw material of Chinese medicine afterwards and Western medicine raw material are put in ethanol solution and are extracted, and extraction time is 3-6 month;By the liquid after extraction
Concentrated, to obtain phalacrosis prevention and hair generation liniment.
Wherein, ethanol solution is wine solution, and its number of degrees is 10-20 degree.
Wherein, wine solution is rice wine solution.
The invention has the beneficial effects as follows: it is different from the situation of prior art, the phalacrosis prevention and hair generation liniment of the present invention includes Chinese medicine
Component and western medicine component, Chinese medicinal components include Radix Ginseng, Radix Angelicae Sinensis, Bulbus Allii, Semen Cuscutae, Radix Rehmanniae, Radix Sophorae Flavescentiss, Rhizoma Polygonati, Fructus Foeniculi, sweetleaf
Chrysanthemum, Fructus Ligustri Lucidi, the Cortex Eucommiae, Herba Lophatheri, Cacumen Platycladi, Herba Menthae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, Folium Ginkgo, Fructus Lycii, Herba Ecliptae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae,
Cover son, Rhizoma Zingiberiss, western medicine component includes vitamin b6, vitamin e, d- pantothenylol, pantothenic acid, Lac regis apis, azelaic acid.This
Bright phalacrosis prevention and hair generation liniment can pass through Chinese medicine ingredients and western medicine composition synergism, realizes phalacrosis prevention and hair generation, and when user uses
No drug dependence.
Specific embodiment
Embodiment 1
Phalacrosis prevention and hair generation liniment includes Chinese medicinal components and western medicine component, and wherein, Chinese medicinal components include Radix Ginseng, Radix Angelicae Sinensis, Bulbus Allii, Herba cuscutae
Son, Radix Rehmanniae, Radix Sophorae Flavescentiss, Rhizoma Polygonati, Fructus Foeniculi, Folium Stevlae Rebaudianae, Fructus Ligustri Lucidi, the Cortex Eucommiae, Herba Lophatheri, Cacumen Platycladi, Herba Menthae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, silver
Folium Pruni, Fructus Lycii, Herba Ecliptae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, cover son, Rhizoma Zingiberiss, western medicine component include vitamin b6, vitamin e, d- pantothenylol,
Pantothenic acid, Lac regis apis, azelaic acid.
In the present embodiment, Chinese medicinal components by weight, including 20 parts of Radix Ginseng, 30 parts of Radix Angelicae Sinensis, 30 parts of Bulbus Allii, Semen Cuscutae
20 parts, 40 parts of Radix Rehmanniae, 20 parts of Radix Sophorae Flavescentiss, 8 parts of Rhizoma Polygonati, 35 parts of Fructus Foeniculi, 35 parts of Folium Stevlae Rebaudianae, 20 parts of Fructus Ligustri Lucidi, 7 parts of the Cortex Eucommiae, phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle
20 parts of leaf, 6 parts of Cacumen Platycladi, 6 parts of Herba Menthae, 30 parts of Radix Polygoni Multiflori, 20 parts of Rhizoma Chuanxiong, 20 parts of Folium Ginkgo, 40 parts of Fructus Lycii, 10 parts of Herba Ecliptae,
9 parts of Radix Saposhnikoviae, 25 parts of Radix Achyranthis Bidentatae, covering sub 20 parts, 25 parts of Rhizoma Zingiberiss;Western medicine component by weight, including 8 parts of vitamin b6,8 parts
Vitamin e, 8 parts of d- pantothenylol, 15 parts of pantothenic acids, 12 parts of Lac regis apis, 20 parts of azelaic acid.
Wherein, each composition in Chinese medicinal components is the extract of each composition.
Wherein, vitamin e is the mixture of tocopherol, tocotrienol or tocopherol and tocotrienol, wherein, fertility
Phenol is Tocopheryl derivatives, and tocotrienol is tocotrienol derivant.
In the present embodiment, the preparation method of phalacrosis prevention and hair generation liniment comprises the following steps:
A. the raw material of Chinese medicine being used for preparing liniment is pulverized.
Raw material of Chinese medicine by weight, including 20 parts of Radix Ginseng, 30 parts of Radix Angelicae Sinensis, 30 parts of Bulbus Allii, 20 parts of Semen Cuscutae, Radix Rehmanniae 40
Part, 20 parts of Radix Sophorae Flavescentiss, 8 parts of Rhizoma Polygonati, 35 parts of Fructus Foeniculi, 35 parts of Folium Stevlae Rebaudianae, 20 parts of Fructus Ligustri Lucidi, 7 parts of the Cortex Eucommiae, 20 parts of Herba Lophatheri, Cacumen Platycladi 6
Part, 6 parts of Herba Menthae, 30 parts of Radix Polygoni Multiflori, 20 parts of Rhizoma Chuanxiong, 20 parts of Folium Ginkgo, 40 parts of Fructus Lycii, 10 parts of Herba Ecliptae, 9 parts of Radix Saposhnikoviae, Radix Achyranthis Bidentatae
25 parts, covering sub 20 parts, 25 parts of Rhizoma Zingiberiss.
B. the raw material of Chinese medicine after pulverizing is mixed with the Western medicine raw material being used for preparing liniment.
Western medicine raw material by weight, including 8 parts of vitamin b6,8 parts of vitamin e, 8 parts of d- pantothenylol, 15 parts of pantothenic acids,
12 parts of Lac regis apis, 20 parts of azelaic acid.
C. mixed raw material of Chinese medicine and Western medicine raw material are put in ethanol solution and extracted, extraction time is 3-6
Month.
Wherein, ethanol solution is wine solution, and its number of degrees is 10-20 degree.The ethanol solution of the present embodiment is rice wine solution, leaching
The time that carries is 6 months.
D. the liquid after extraction is concentrated, to obtain phalacrosis prevention and hair generation liniment.
200 experimenters having a different degrees of alopecia symptom use the liniments of the present embodiment, and using method is particularly as follows: one day
Twice, with liniment wipe in need improve and need hair growth promoting the crown on, massage 3 to 4 minutes.Specific as follows using result: using 1 month
Afterwards, the alopecia symptom of experimenter all mitigates;After 3 months, the position of 120 its wiping liniments of experimenter has bob to grow,
The position of 60 its wiping liniments of experimenter has sparse undercoat to grow, and 20 experimenters no newly send out and grow.After 6 months, 170
Example experimenter's liniment cleaning part potential head is sent out dense, and 20 experimenter's liniments wipe position has bob to grow, and 10 experimenters are no new
Send out and grow.
The experimenter that sends out dense for above-mentioned 170 liniment cleaning part potential heads so as to disable the present embodiment liniment 30 days, 30
After it, the hair of this 170 experimenters all no substantially changes, and the liniment no drug dependence of the present embodiment is described.
Embodiment 2
Phalacrosis prevention and hair generation liniment includes Chinese medicinal components and western medicine component, and wherein, Chinese medicinal components include Radix Ginseng, Radix Angelicae Sinensis, Bulbus Allii, Herba cuscutae
Son, Radix Rehmanniae, Radix Sophorae Flavescentiss, Rhizoma Polygonati, Fructus Foeniculi, Folium Stevlae Rebaudianae, Fructus Ligustri Lucidi, the Cortex Eucommiae, Herba Lophatheri, Cacumen Platycladi, Herba Menthae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, silver
Folium Pruni, Fructus Lycii, Herba Ecliptae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, cover son, Rhizoma Zingiberiss, western medicine component include vitamin b6, vitamin e, d- pantothenylol,
Pantothenic acid, Lac regis apis, azelaic acid.
In the present embodiment, Chinese medicinal components by weight, including 10 parts of Radix Ginseng, 10 parts of Radix Angelicae Sinensis, 50 parts of Bulbus Allii, Semen Cuscutae
30 parts, 20 parts of Radix Rehmanniae, 10 parts of Radix Sophorae Flavescentiss, 10 parts of Rhizoma Polygonati, 20 parts of Fructus Foeniculi, 50 parts of Folium Stevlae Rebaudianae, 10 parts of Fructus Ligustri Lucidi, 10 parts of the Cortex Eucommiae, light
30 parts of Folium Bambusae, 10 parts of Cacumen Platycladi, 10 parts of Herba Menthae, 45 parts of Radix Polygoni Multiflori, 10 parts of Rhizoma Chuanxiong, 30 parts of Folium Ginkgo, 15 parts of Fructus Lycii, Herba Ecliptae 8
Part, 5 parts of Radix Saposhnikoviae, 10 parts of Radix Achyranthis Bidentatae, covering sub 30 parts, 30 parts of Rhizoma Zingiberiss;Western medicine component by weight, including 2 parts of vitamin b6,
2 parts of vitamin e, 2 parts of d- pantothenylol, 10 parts of pantothenic acids, 15 parts of Lac regis apis, 30 parts of azelaic acid.
Wherein, each composition in Chinese medicinal components is the extract of each composition.
Wherein, vitamin e is the mixture of tocopherol, tocotrienol or tocopherol and tocotrienol, wherein, fertility
Phenol is Tocopheryl derivatives, and tocotrienol is tocotrienol derivant.
In the present embodiment, the preparation method of phalacrosis prevention and hair generation liniment comprises the following steps:
A. the raw material of Chinese medicine being used for preparing liniment is pulverized.
Raw material of Chinese medicine by weight, including 10 parts of Radix Ginseng, 10 parts of Radix Angelicae Sinensis, 50 parts of Bulbus Allii, 30 parts of Semen Cuscutae, Radix Rehmanniae 20
Part, 10 parts of Radix Sophorae Flavescentiss, 10 parts of Rhizoma Polygonati, 20 parts of Fructus Foeniculi, 50 parts of Folium Stevlae Rebaudianae, 10 parts of Fructus Ligustri Lucidi, 10 parts of the Cortex Eucommiae, 30 parts of Herba Lophatheri, Cacumen Platycladi
10 parts of leaf, 10 parts of Herba Menthae, 45 parts of Radix Polygoni Multiflori, 10 parts of Rhizoma Chuanxiong, 30 parts of Folium Ginkgo, 15 parts of Fructus Lycii, 8 parts of Herba Ecliptae, 5 parts of Radix Saposhnikoviae, bosom
10 parts of Radix Achyranthis Bidentatae, covering sub 30 parts, 30 parts of Rhizoma Zingiberiss.
B. the raw material of Chinese medicine after pulverizing is mixed with the Western medicine raw material being used for preparing liniment.
Western medicine raw material by weight, including 2 parts of vitamin b6,2 parts of vitamin e, 2 parts of d- pantothenylol, 10 parts of pantothenic acids,
15 parts of Lac regis apis, 30 parts of azelaic acid.
C. mixed raw material of Chinese medicine and Western medicine raw material are put in ethanol solution and extracted, extraction time is 3-6
Month.
Wherein, ethanol solution is wine solution, and its number of degrees is 10-20 degree.The ethanol solution of the present embodiment is rice wine solution, leaching
The time that carries is 6 months.
D. the liquid after extraction is concentrated, to obtain phalacrosis prevention and hair generation liniment.
200 experimenters having a different degrees of alopecia symptom use the liniments of the present embodiment, and using method is particularly as follows: one day
Twice, with liniment wipe in need improve and need hair growth promoting the crown on, massage 3 to 4 minutes.Specific as follows using result: using 1 month
Afterwards, the alopecia symptom of experimenter all mitigates;After 3 months, the position of 110 its wiping liniments of experimenter has bob to grow,
The position of 50 its wiping liniments of experimenter has sparse undercoat to grow, and 40 experimenters no newly send out and grow.After 6 months, 160
Example experimenter's liniment cleaning part potential head is sent out dense, and 19 experimenter's liniments wipe position has bob to grow, and 21 experimenters are no new
Send out and grow.
The experimenter that sends out dense for above-mentioned 160 liniment cleaning part potential heads so as to disable the present embodiment liniment 30 days, 30
After it, the hair of this 160 experimenters all no substantially changes, and the liniment no drug dependence of the present embodiment is described.
In sum, embodiment 1 is the preferred embodiments of the present invention, and the phalacrosis prevention and hair generation liniment of the present invention can be become by Chinese medicine
Divide and western medicine composition synergism, realize phalacrosis prevention and hair generation, and no drug dependence when user uses.
The foregoing is only embodiments of the invention, not thereby limit the present invention the scope of the claims, every using this
Equivalent structure or equivalent flow conversion that bright description is made, or directly or indirectly it is used in other related technology necks
Domain, is included within the scope of the present invention.
Claims (8)
1. it is characterised in that including Chinese medicinal components and western medicine component, described Chinese medicinal components include people to a kind of phalacrosis prevention and hair generation liniment
Ginseng, Radix Angelicae Sinensis, Bulbus Allii, Semen Cuscutae, Radix Rehmanniae, Radix Sophorae Flavescentiss, Rhizoma Polygonati, Fructus Foeniculi, Folium Stevlae Rebaudianae, Fructus Ligustri Lucidi, the Cortex Eucommiae, Herba Lophatheri, Cacumen Platycladi, thin
Lotus, Radix Polygoni Multiflori, Rhizoma Chuanxiong, Folium Ginkgo, Fructus Lycii, Herba Ecliptae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, covering, Rhizoma Zingiberiss, described western medicine component includes tieing up
Raw element b6, vitamin e, d- pantothenylol, pantothenic acid, Lac regis apis, azelaic acid.
2. phalacrosis prevention and hair generation liniment according to claim 1 it is characterised in that described Chinese medicinal components by weight, including
Radix Ginseng 10-30 part, Radix Angelicae Sinensis 10-40 part, Bulbus Allii 10-50 part, Semen Cuscutae 10-30 part, Radix Rehmanniae 20-50 part, Radix Sophorae Flavescentiss 10-30 part,
Rhizoma Polygonati 2-10 part, Fructus Foeniculi 20-50 part, Folium Stevlae Rebaudianae 20-50 part, Fructus Ligustri Lucidi 10-30 part, Cortex Eucommiae 2-10 part, Herba Lophatheri 10-30 part,
Cacumen Platycladi 2-10 part, Herba Menthae 2-10 part, Radix Polygoni Multiflori 10-45 part, Rhizoma Chuanxiong 10-30 part, Folium Ginkgo 10-30 part, Fructus Lycii 15-45 part,
Herba Ecliptae 8-15 part, Radix Saposhnikoviae 5-10 part, Radix Achyranthis Bidentatae 10-30 part, the sub- 10-30 part of covering, Rhizoma Zingiberiss 10-30 part;
Described western medicine component by weight, including 2-10 part vitamin b6,2-10 part vitamin e, 2-10 part d- pantothenylol, 10-
20 parts of pantothenic acids, 5-15 part Lac regis apis, 10-30 part azelaic acid.
3. phalacrosis prevention and hair generation liniment according to claim 2 it is characterised in that described Chinese medicinal components by weight, including
20 parts of Radix Ginseng, 30 parts of Radix Angelicae Sinensis, 30 parts of Bulbus Allii, 20 parts of Semen Cuscutae, 40 parts of Radix Rehmanniae, 20 parts of Radix Sophorae Flavescentiss, 8 parts of Rhizoma Polygonati, 35 parts of Fructus Foeniculi, sweet
35 parts of leaf chrysanthemum, 20 parts of Fructus Ligustri Lucidi, 7 parts of the Cortex Eucommiae, 20 parts of Herba Lophatheri, 6 parts of Cacumen Platycladi, 6 parts of Herba Menthae, 30 parts of Radix Polygoni Multiflori, 20 parts of Rhizoma Chuanxiong,
20 parts of Folium Ginkgo, 40 parts of Fructus Lycii, 10 parts of Herba Ecliptae, 9 parts of Radix Saposhnikoviae, 25 parts of Radix Achyranthis Bidentatae, covering sub 20 parts, 25 parts of Rhizoma Zingiberiss;
Described western medicine component by weight, including 8 parts of vitamin b6,8 parts of vitamin e, 8 parts of d- pantothenylol, 15 parts of pantothenic acids,
12 parts of Lac regis apis, 20 parts of azelaic acid.
4. phalacrosis prevention and hair generation liniment according to claim 3 it is characterised in that described vitamin e be tocopherol, triolefin fertility
Phenol or the mixture of tocopherol and tocotrienol, wherein, described tocopherol is Tocopheryl derivatives, and described tocotrienol is
Tocotrienol derivant.
5. phalacrosis prevention and hair generation liniment according to claim 4 is it is characterised in that each composition in described Chinese medicinal components is respectively
The extract of composition.
6. the preparation method of phalacrosis prevention and hair generation liniment described in claim 1-5 any one is it is characterised in that comprise the following steps:
The raw material of Chinese medicine being used for preparing described liniment is pulverized, described raw material of Chinese medicine includes Radix Ginseng, Radix Angelicae Sinensis, Bulbus Allii, Herba cuscutae
Son, Radix Rehmanniae, Radix Sophorae Flavescentiss, Rhizoma Polygonati, Fructus Foeniculi, Folium Stevlae Rebaudianae, Fructus Ligustri Lucidi, the Cortex Eucommiae, Herba Lophatheri, Cacumen Platycladi, Herba Menthae, Radix Polygoni Multiflori, Rhizoma Chuanxiong, silver
Folium Pruni, Fructus Lycii, Herba Ecliptae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, covering, Rhizoma Zingiberiss;
Raw material of Chinese medicine after pulverizing is mixed with the Western medicine raw material being used for preparing described liniment, described Western medicine raw material includes tieing up
Raw element b6, vitamin e, d- pantothenylol, pantothenic acid, Lac regis apis, azelaic acid;
Mixed raw material of Chinese medicine and Western medicine raw material are put in ethanol solution and extracted, extraction time is 3-6 month;
Liquid after extraction is concentrated, to obtain phalacrosis prevention and hair generation liniment.
7. the preparation method of phalacrosis prevention and hair generation liniment according to claim 6 is it is characterised in that described ethanol solution is that wine is molten
Liquid, its number of degrees is 10-20 degree.
8. the preparation method of phalacrosis prevention and hair generation liniment according to claim 7 is it is characterised in that described wine solution is that rice wine is molten
Liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610955858.2A CN106334178A (en) | 2016-11-03 | 2016-11-03 | Alopecia-preventing and hair growth promoting liniment and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610955858.2A CN106334178A (en) | 2016-11-03 | 2016-11-03 | Alopecia-preventing and hair growth promoting liniment and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106334178A true CN106334178A (en) | 2017-01-18 |
Family
ID=57840858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610955858.2A Pending CN106334178A (en) | 2016-11-03 | 2016-11-03 | Alopecia-preventing and hair growth promoting liniment and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106334178A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111956568A (en) * | 2020-07-07 | 2020-11-20 | 中山职业技术学院 | Shaving water with hair growing and hair loss preventing functions and preparation method thereof |
CN113144126A (en) * | 2021-04-26 | 2021-07-23 | 杨智芳 | Compound Chinese medicinal preparation for promoting hair growth, preventing whitening, controlling oil and removing dandruff, and its preparation method and application |
CN116870074A (en) * | 2023-08-14 | 2023-10-13 | 江苏春申堂药业有限公司 | Chinese medicinal liniment for preventing hair loss and promoting hair growth, and its preparation method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1706437A (en) * | 2005-05-27 | 2005-12-14 | 王家军 | Combined Chinese and Western medicine liniment for treating seborrheic baldness |
CN103623073A (en) * | 2013-12-09 | 2014-03-12 | 百花医药集团股份有限公司 | Method for preparing six-ingredient anti-hair-loss and hair-restoring preparation for external use |
CN104721278A (en) * | 2014-12-27 | 2015-06-24 | 陈正梅 | Formula of medicine for preventing hair loss and growing hair |
-
2016
- 2016-11-03 CN CN201610955858.2A patent/CN106334178A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1706437A (en) * | 2005-05-27 | 2005-12-14 | 王家军 | Combined Chinese and Western medicine liniment for treating seborrheic baldness |
CN103623073A (en) * | 2013-12-09 | 2014-03-12 | 百花医药集团股份有限公司 | Method for preparing six-ingredient anti-hair-loss and hair-restoring preparation for external use |
CN104721278A (en) * | 2014-12-27 | 2015-06-24 | 陈正梅 | Formula of medicine for preventing hair loss and growing hair |
Non-Patent Citations (1)
Title |
---|
王绪前: "《中医膏方大全》", 30 September 2019, 中国医药科技出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111956568A (en) * | 2020-07-07 | 2020-11-20 | 中山职业技术学院 | Shaving water with hair growing and hair loss preventing functions and preparation method thereof |
CN113144126A (en) * | 2021-04-26 | 2021-07-23 | 杨智芳 | Compound Chinese medicinal preparation for promoting hair growth, preventing whitening, controlling oil and removing dandruff, and its preparation method and application |
CN116870074A (en) * | 2023-08-14 | 2023-10-13 | 江苏春申堂药业有限公司 | Chinese medicinal liniment for preventing hair loss and promoting hair growth, and its preparation method |
CN116870074B (en) * | 2023-08-14 | 2024-05-17 | 江苏春申堂药业有限公司 | Chinese medicinal liniment for preventing hair loss and promoting hair growth, and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432043A (en) | Face mask containing plant material residues | |
CN107495367B (en) | Food, health-care product or pharmaceutical composition for improving anoxia resistance and preparation method and application thereof | |
CN111714425B (en) | Shampoo composition for improving scalp and hair condition | |
CN106334178A (en) | Alopecia-preventing and hair growth promoting liniment and preparation method thereof | |
CN104107161A (en) | Mouthwash used for nursing oral cavity and preparation method thereof | |
KR19980086246A (en) | Extraction method of hair growth promoting ingredient from herbal medicine and extract thereof | |
Pundkar et al. | A review: Herbal therapy used in hair loss | |
CN102113980A (en) | Pure Chinese medicinal whitening mask | |
CN101062347A (en) | Chinese traditional medicine formula good for heart and brain | |
CN104800445A (en) | Whitening medicine recipe | |
CN102988608B (en) | Chinese medicinal composition for treating alopecia areata | |
CN104857321A (en) | Medicine for treating leukotrichia and baldness and preparation method of medicine | |
CN107998211B (en) | Hair nourishing composition and preparation method and application thereof | |
CN105148047A (en) | Traditional Chinese medicine decoction for treating breast milk stoppage | |
CN104509847A (en) | Halitosis treating honeyed pill | |
CN1977810A (en) | Plant whitening function lotion | |
CN107224572A (en) | A kind of functions of removing chloasma capsule and preparation method thereof | |
CN104398450A (en) | Natural moistening sunscreen cream containing chestnut extractive | |
CN102525872A (en) | Hair renewal fluid and manufacture method thereof | |
CN102274468B (en) | Chinese medicinal composition for regulating female internal secretion and preparation method thereof | |
CN104857417A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
CN104491401A (en) | Traditional Chinese medicine composition for treating blood-deficiency headache | |
CN1977809A (en) | Plant anti-wrinkle function lotion | |
CN104491175A (en) | Hair care medicine | |
CN103349685A (en) | Traditional Chinese medicine comprising radix paeoniae rubra and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170118 |